BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28618047)

  • 1. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
    Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
    Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
    Sempoux C; Gouw ASH; Dunet V; Paradis V; Balabaud C; Bioulac-Sage P
    Am J Surg Pathol; 2021 Apr; 45(4):477-487. PubMed ID: 33560657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
    van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
    J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
    Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
    Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.
    Sempoux C; Bisig B; Couchy G; Balabaud C; Zucman-Rossi J; Bioulac-Sage P
    Hum Pathol; 2017 Apr; 62():122-125. PubMed ID: 27984126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
    Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
    Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
    Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
    Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular Adenoma in an Infant With Burn-McKeown Syndrome: Report of a Case.
    González IA; Surrey LF; Russo P
    Pediatr Dev Pathol; 2022; 25(6):668-671. PubMed ID: 36262073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
    Larson BK; Guindi M
    Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
    Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P
    J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
    Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
    Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation.
    Berry RS; Gullapalli RR; Wu J; Morris K; Hanson JA
    Virchows Arch; 2014 Aug; 465(2):241-5. PubMed ID: 24997695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation.
    Sorkin T; Strautnieks S; Foskett P; Peddu P; Thompson RJ; Heaton N; Quaglia A
    Hum Pathol; 2016 Jul; 53():153-8. PubMed ID: 27038679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.
    Jo VY; Sholl LM; Krane JF
    Am J Surg Pathol; 2016 Aug; 40(8):1143-50. PubMed ID: 27259009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
    Rebouissou S; Franconi A; Calderaro J; Letouzé E; Imbeaud S; Pilati C; Nault JC; Couchy G; Laurent A; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
    Hepatology; 2016 Dec; 64(6):2047-2061. PubMed ID: 27177928
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
    Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis.
    Yan Z; Grenert JP; Joseph NM; Ren C; Chen X; Shafizadeh N; Kakar S
    Histopathology; 2018 Jul; 73(1):101-108. PubMed ID: 29512829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
    Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.